If you’ve experienced a heart attack, your healthcare provider may prescribe certain medications to help prevent one from ...

Antiplatelets are particularly beneficial for people who have had a previous heart attack or stroke, those with CAD, or ...

According to US secondary stroke prevention guidelines, patients with ESUS should not be treated with anticoagulants or ...

CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing therapeutic products for life-threatening diseases and conditions, today announced that it has entered into a new ...

In a recent study published in the scientific journal "Blood", researchers from MedUni Vienna show that hemorrhages are more common in cancer patients than previously thought and are associated with a ...

Dashboard was developed by the VA in 2016 to highlight and optimize the treatment of patients with direct oral anticoagulants ...

Heparin bridging during the resumption of anticoagulation post-intracranial hemorrhage may be linked to an increased risk for bleeding.

BACKGROUND: The European Chronic Thromboembolic Pulmonary Hypertension registry (CTEPH), conducted between 2007 and 2012, reported the major impact of pulmonary endarterectomy (PEA) on the long-term ...

CVKD READ THE FULL CVKD RESEARCH REPORT We are initiating coverage of Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) with a $30.00 valuation. Cadrenal is a biopharmaceutical developing innovative therapies ...

Brazilian researchers from UFRJ and INBEB uncover how mutant p53, a key tumor suppressor, transforms proteins like p63 and ...